This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board meeting on Aug 3 to consider Q1 FY27 unaudited results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.6 pts less than Nifty Microcap 250 and 2.2 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
National Peroxide Limited has informed BSE that its Board of Directors will meet on Monday, August 3, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27). The intimation is filed under Regulation 29 of SEBI Listing Regulations. No further details were disclosed in the notice.
Routine intimation. Watch for Q1 results announcement on Aug 3 for revenue, profit and margin trends.
| Q1 FY27 | Q1 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹96.07 Cr | ₹66.66 Cr | +44.1% |
| Operating profit | ₹6.71 Cr | −₹0.67 Cr | turned positive |
| Profit after tax | ₹6.61 Cr | ₹0.89 Cr | +642.3% |
| EBITDA margin | 12.7% | 7.2% | +5.5 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.